Repligen
RGEN
#2665
Rank
A$9.17 B
Marketcap
A$162.59
Share price
-0.94%
Change (1 day)
-25.94%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): A$0.12 Billion

According to Repligen 's latest financial reports the company's current earnings are A$0.73 Billion. , an increase over its 2024 earnings that were of -A$8.75 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year Earnings Change
2025 A$0.11 B-1430.84%
2024 -A$8.75 Million-113.01%
2023 A$67.21 M-78.01%
2022 A$0.30 B33.37%
2021 A$0.22 B131.52%
2020 A$98.98 M101.31%
2019 A$49.17 M25.93%
2018 A$39.04 M105.61%
2017 A$18.99 M-11.46%
2016 A$21.44 M14.91%
2015 A$18.66 M20.26%
2014 A$15.52 M-51.49%
2013 A$31.99 M90.98%
2012 A$16.75 M
2010 A$0.24 M-103.81%
2009 -A$6.37 Million-223.84%
2008 A$5.13 M
2006 -A$3.46 Million229.64%
2005 -A$1.05 Million-89.16%
2004 -A$9.67 Million-16.86%
2003 -A$11.63 Million88.72%
2002 -A$6.16 Million-27.88%
2001 -A$8.54 Million-1.74%
2000 -A$8.7 Million85.93%
1999 -A$4.68 Million159.16%
1998 -A$1.81 Million85.71%
1997 -A$0.98 Million-70.83%
1996 -A$3.33 Million-72.41%
1995 -A$12.07 Million-60.63%
1994 -A$30.66 Million45.39%
1993 -A$21.09 Million39.45%
1992 -A$15.13 Million-32.3%
1991 -A$22.34 Million6.62%
1990 -A$20.95 Million1577.78%
1989 -A$1.25 Million-57.14%
1988 -A$2.92 Million-362.5%
1987 A$1.1 M-130.77%
1986 -A$3.61 Million136.36%
1985 -A$1.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$14.13 B 12,048.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$10.13 B 8,610.78%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
A$15.04 B 12,824.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.94 B 11,018.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-A$0.16 Billion-229.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
A$0.64 B 453.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$0.88 B 658.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
A$0.17 B 47.18%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.66 B 475.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-A$0.14 Billion-218.60%๐Ÿ‡บ๐Ÿ‡ธ USA